200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 146163-06-6

146163-06-6

146163-06-6 | L-Valinamide, L-seryl-L-isoleucyl-L-lysyl-L-valyl-L-alanyl-

CAS No: 146163-06-6 Catalog No: AG001DR7 MDL No:

Product Description

Catalog Number:
AG001DR7
Chemical Name:
L-Valinamide, L-seryl-L-isoleucyl-L-lysyl-L-valyl-L-alanyl-
CAS Number:
146163-06-6
Molecular Formula:
C28H54N8O7
Molecular Weight:
614.7778
IUPAC Name:
(2S)-6-amino-2-[[(2S,3S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]hexanamide
InChI:
InChI=1S/C28H54N8O7/c1-8-16(6)22(36-25(40)18(30)13-37)28(43)33-19(11-9-10-12-29)26(41)35-21(15(4)5)27(42)32-17(7)24(39)34-20(14(2)3)23(31)38/h14-22,37H,8-13,29-30H2,1-7H3,(H2,31,38)(H,32,42)(H,33,43)(H,34,39)(H,35,41)(H,36,40)/t16-,17-,18-,19-,20-,21-,22-/m0/s1
InChI Key:
PIRVHLUVWWMELB-CPDXTSBQSA-N
SMILES:
NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)C(C)C)C)C(C)C)NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@H](CO)N

Properties

Complexity:
946  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
7  
Defined Bond Stereocenter Count:
0
Exact Mass:
614.412g/mol
Formal Charge:
0
Heavy Atom Count:
43  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
9  
Isotope Atom Count:
0
Molecular Weight:
614.789g/mol
Monoisotopic Mass:
614.412g/mol
Rotatable Bond Count:
20  
Topological Polar Surface Area:
261A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.7  

Literature

Title Journal
SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway. The American journal of pathology 20070701
Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins. Cancer gene therapy 20070401
Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling. Anti-cancer drugs 20060401
Laminin-1 and SIKVAV a laminin-1-derived peptide, regulate the morphology and protease activity of a human salivary gland adenoid cystic carcinoma cell line. Oral oncology 20040501
In vitro effects of SIKVAV retro and retro-enantio analogues on tumor metastatic events. Peptides 20040201
The effect of laminin and its peptide SIKVAV on a human salivary gland myoepithelioma cell line. Oral oncology 20040101
The effect of laminin and its peptide SIKVAV on a human salivary gland adenoid cystic carcinoma cell line. Virchows Archiv : an international journal of pathology 20021201
[Biological activity of synthetic analogs of laminin active sequences: YIGSR, RGD, SIKVAV]. Postepy higieny i medycyny doswiadczalnej 20020101

© 2019 Angene International Limited. All rights Reserved.